Report Overview

2023

Base Year

2018-2023

Historical Year

2024-2032

Forecast Year

Global Lung Cancer Therapeutics Market Size

The global lung cancer therapeutics market attained a value of USD 31.92 billion in 2023. The market is likely to grow at a CAGR of 11.60% during the forecast period of 2024-2032 to attain a value of USD 85.71 billion by 2032.

 

Lung Cancer Therapeutics Market Report Snapshots

Lung Cancer Therapeutics Market Size

Lung Cancer Therapeutics Market Trends

Lung Cancer Therapeutics Companies

 

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Outline the Scope

Key Questions Answered in the Report

The lung cancer therapeutics market was valued at USD 31.92 billion in 2023.

The market is expected to grow at a CAGR of 11.60% from 2024 to 2032 to reach a value of USD 85.71 billion by 2032.

The lung cancer therapeutics market is driven by the rising development of technology for treatment and diagnosis and an increasing number of cases due to the growth of the smoking population.

Governments are implementing plans to develop their healthcare infrastructure and organisations’ increasing focus on research and development to launch new and innovative treatment solutions are key trends in the market.

The regional markets for the global lung therapeutics market include North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa.

There are two main types of cancer available in the market for cancer therapeutics including non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), among others.

The market segments for lung cancer therapeutics, based on therapy, include Chemotherapy, Immunotherapy, Radiation Therapy, and Targeted Therapy, among others.

These therapeutics find end-uses in hospitals, home care, and speciality clinics, among others.

The distribution channels in the market for lung cancer therapeutics include hospital pharmacies, retail pharmacies, and online.

If surgery is excluded from the options, combined chemotherapy and radiation therapy is the primary treatment used for lung cancer. For advanced lung cancers, radiation therapy can help in relieving pain and slowing down the advancement of cancer.

The United States Food and Drug Administration has approved Lumakras (sotorasib) for the treatment of non-small cell lung cancer in adult patients whose tumours have a specific genetic mutation known as KRAS G12C.

The key players in the market include Genentech, Inc., AstraZeneca PLC, Novartis AG., Merck KGaA, F. Hoffmann-La Roche Ltd, and Boehringer Ingelheim International GmbH, among others.

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,499

tax inclusive*

Get Started
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,699

tax inclusive*

Get Started
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,599

tax inclusive*

Get Started
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,599

tax inclusive*

Get Started
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Gain insights to stay ahead and seize opportunities.

Get insights & trends for a competitive edge.

Track prices with detailed trend reports.

Analyse trade data for supply chain insights.

Leverage cost reports for smart savings

Enhance supply chain with partnerships.

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Request Brochure

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Get To Know Us

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

Our Services

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

Markets We Cover
Back to top

We’re here to help answer any questions about our products and services.

Contact us

Get In Touch

Our Offices

Australia

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63-287-899-028, +63-967-048-3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63-287-899-028, +63-967-048-3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124

Quick Links

Who We Are

What We Offer

 

© 2024 Claight Corp. All Rights Reserved

$getforecastarray = array(); if (isset($ismapshow)) { $forecast_period_start = isset($forecast_period_start) ? $forecast_period_start : ''; if ($forecast_period_start != "") { $yearInc = 1; for ($startfrom = $forecast_period_start; $startfrom <= $forecast_period_end; $startfrom++) { $calculatFercastYear=calculateFutureValue(($getReportDetail['base_value']> 0) ? $getReportDetail['base_value'] : 100, $getReportDetail['cagr'], $yearInc); $getforecastarray[] = array('years' => "$startfrom", 'value' => $calculatFercastYear); $yearInc++; } } } $getforecastarrayJson = json_encode($getforecastarray); ?>